Kevin Stokesbury, Professor of Fisheries Oceanography at UMass Dartmouth’s School for Marine Science & Technology (SMAST), has been elected to the National Academy of Sciences’ Committee on the Assessment and Advancement of Science in the Bureau of Ocean Energy Management's (BOEM) Environmental Studies Program.

In the United States, February is designated as “Black History Month”, a time when Americans of all walks of life honor and appreciate the contributions of Americans of African descent in the areas of science and medicine, philosophy, law, literature, politics, visual and performing arts, athletics, music and more. From George Washington Carver to Dr. Mae C. Jemison; from Phillis Wheatley to James Baldwin; from Charlotte E.

The ideas ran the gamut: from the bold vision of installing wind turbines under the Howe Bridge to the community-oriented plan of closing a street in downtown Lowell once a week for a farmer’s market.

But in the end, it was a strategy to boost ridership on Lowell’s city buses that won the second annual Climate Mitigation Challenge, sponsored by the Rist Institute for Sustainability and Energy (RISE).

Reflecting on his 30-year career in the pharmaceutical industry, Jerry St. Peter ’89 sees a direct connection between his UMass Lowell experience and his success. 

“When I look back on my time at the university, everything I’ve accomplished began there with faculty preparing me to excel and explore my potential,” says St. Peter, a Lowell native who is the cofounder, CEO and a board member of Eyevance Pharmaceuticals, an ophthalmic company based in Fort Worth, Texas. 

AMHERST, Mass. – The University of Massachusetts Amherst has launched a new Black Presence Initiative. The Initiative, spearheaded by the Office of Equity and Inclusion, is coordinating a series of actions designed to document and honor the contributions of Black students, faculty and staff to the campus.

Worcester HIV Vaccine, a biotechnology company dedicated to the development of a vaccine to prevent HIV infections around the world, has received clearance from the U.S. Food and Drug Administration for its Investigational New Drug application for a novel polyvalent DNA/prime-protein boost vaccine to prevent HIV, called PDPHV. The application calls for the Worcester-based start-up to explore vaccination designs in a Phase I b clinical trial to be launched in February. A Phase II clinical trial is expected to follow.

The U.S. faces one of the most consequential public health campaigns in history right now: to vaccinate the population against COVID-19 and, especially, to get shots into the arms of people who cannot easily navigate getting vaccinated on their own.

Time is of the essence. As new, potentially more dangerous variants of this coronavirus spread to new regions, widespread vaccination is one of the most powerful and effective ways to slow, if not stop, the virus’s spread.

A team of researchers led by Chemistry Asst. Prof. Manos Gkikas is developing an advanced X-ray imaging method that aims to improve the detection and diagnosis of breast cancer. 

During the coronavirus pandemic that has forced many people to rethink how they use their forced time at home during social distancing and quarantines, UMass Boston Associate Professor of Biology Liam Revell decided to take on a new project: develop a website that enables users to interact with COVID-19 data over time and visibly see trends with dynamic graphics.

BOSTON – Online programs at the University of Massachusetts received high marks again in the 10th annual Best Online Programs rankings by U.S. News & World Report, which assessed more than 1,000 programs nationwide.